mRNSvakcinák
mRNSvakcinák, or messenger RNA vaccines, are a type of vaccine that uses a small piece of messenger RNA (mRNA) to instruct cells to produce a specific protein, which then triggers an immune response. This approach was pioneered by the mRNA-1273 vaccine developed by Moderna and the BNT162b2 vaccine developed by Pfizer-BioNTech. These vaccines have been widely used in the COVID-19 pandemic to prevent infection with the SARS-CoV-2 virus.
The mRNA in these vaccines is designed to encode a protein that is similar to a protein
One of the advantages of mRNA vaccines is that they can be produced quickly and in large
In summary, mRNSvakcinák are a promising new approach to vaccine development that has shown great success in